Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L18 (rplR) CSB-YP481780BTB
CSB-EP481780BTB
CSB-BP481780BTB
CSB-MP481780BTB
CSB-EP481780BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 30S ribosomal protein S17 (rpsQ) CSB-YP481781BTB
CSB-EP481781BTB
CSB-BP481781BTB
CSB-MP481781BTB
CSB-EP481781BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L22 (rplV) CSB-YP481782BTB
CSB-EP481782BTB
CSB-BP481782BTB
CSB-MP481782BTB
CSB-EP481782BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 30S ribosomal protein S9 (rpsI) CSB-YP481783BTB
CSB-EP481783BTB
CSB-BP481783BTB
CSB-MP481783BTB
CSB-EP481783BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L1 (rplA) CSB-YP481784BTB
CSB-EP481784BTB
CSB-BP481784BTB
CSB-MP481784BTB
CSB-EP481784BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP481785BTB
CSB-EP481785BTB
CSB-BP481785BTB
CSB-MP481785BTB
CSB-EP481785BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis tRNA (guanine-N (7)-)-methyltransferase CSB-YP481786BTB
CSB-EP481786BTB
CSB-BP481786BTB
CSB-MP481786BTB
CSB-EP481786BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Methionine--tRNA ligase (metG), partial CSB-YP481787BTB
CSB-EP481787BTB
CSB-BP481787BTB
CSB-MP481787BTB
CSB-EP481787BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis DNA ligase (ligA), partial CSB-YP481788BTB
CSB-EP481788BTB
CSB-BP481788BTB
CSB-MP481788BTB
CSB-EP481788BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Glutamate racemase (murI) CSB-YP481789BTB
CSB-EP481789BTB
CSB-BP481789BTB
CSB-MP481789BTB
CSB-EP481789BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP481790BTB
CSB-EP481790BTB
CSB-BP481790BTB
CSB-MP481790BTB
CSB-EP481790BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis 50S ribosomal protein L20 (rplT) CSB-YP481791BTB
CSB-EP481791BTB
CSB-BP481791BTB
CSB-MP481791BTB
CSB-EP481791BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Threonine--tRNA ligase (thrS), partial CSB-YP481792BTB
CSB-EP481792BTB
CSB-BP481792BTB
CSB-MP481792BTB
CSB-EP481792BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP481793BTB
CSB-EP481793BTB
CSB-BP481793BTB
CSB-MP481793BTB
CSB-EP481793BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP481794BTB1
CSB-EP481794BTB1
CSB-BP481794BTB1
CSB-MP481794BTB1
CSB-EP481794BTB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Elongation factor 4 (lepA), partial CSB-YP481795BTB
CSB-EP481795BTB
CSB-BP481795BTB
CSB-MP481795BTB
CSB-EP481795BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Chorismate synthase (aroC) CSB-YP481796BTB
CSB-EP481796BTB
CSB-BP481796BTB
CSB-MP481796BTB
CSB-EP481796BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis UPF0145 protein Blon_0093/BLIJ_0092 (Blon_0093, BLIJ_0092) CSB-YP481797BTB
CSB-EP481797BTB
CSB-BP481797BTB
CSB-MP481797BTB
CSB-EP481797BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis UvrABC system protein B (uvrB), partial CSB-YP481798BTB
CSB-EP481798BTB
CSB-BP481798BTB
CSB-MP481798BTB
CSB-EP481798BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bifidobacterium longum subsp. infantis Recombination protein RecR (recR) CSB-YP481799BTB
CSB-EP481799BTB
CSB-BP481799BTB
CSB-MP481799BTB
CSB-EP481799BTB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>